# Genomic characterisation of extensively drug-resistant Acinetobacter baumannii isolates from a tertiary hospital in Ghana

## TL;DR

This study characterizes drug-resistant Acinetobacter baumannii in Ghana, revealing the presence of multiple antibiotic resistance genes and high-risk clones.

## Contribution

The study reports the first detection of specific high-risk clones (ST2 and ST164) producing carbapenemase genes in Ghana.

## Key findings

- 18 out of 65 A. baumannii isolates were carbapenem resistant.
- blaNDM-1 was the most common resistance gene, often co-occurring with blaOXA-23 or blaOXA-58.
- Sequence types ST2 and ST164 were identified as high-risk clones in clinical isolates.

## Abstract

Acinetobacter baumannii (A. baumannii) is an emerging “superbug” whose infections have become extremely difficult to treat due to its diverse antimicrobial resistance mechanisms and resistance to last-resort antibiotics including carbapenems. Despite this, data on genetic determinants and genomic context of carbapenemase genes in A. baumannii are scarce in Ghana. This study investigated the genetic determinants of carbapenem resistance in clinical isolates of A. baumannii (Ab) and explored the genetic contexts of carbapenemase-encoding genes in extensively drug-resistant A. baumannii (XDR-Ab). We analysed 65 archived clinical A. baumannii isolates. Identification and antimicrobial susceptibility profiles of the isolates were determined using a MALDI-TOF-MS and the Microscan device, respectively. Carbapenem resistant A. baumannii (CR-Ab) isolates were screened for carbapenemase-encoding genes (blaNDM-1, blaKPC, blaVIM, blaOXA-48, blaOXA-23, blaOXA-58, and blaIMP) using loop-mediated isothermal amplification (LAMP). Six XDR-Ab isolates were whole-genome sequenced (WGS) using Nanopore MinION. Carbapenem resistance was observed in 18/65 (27.7%) isolates. All CR isolates were resistant to penicillins, cephalosporins, fluroquinolones, aminoglycosides, sulfonamides and carbapenems (minimum inhibitory concentrations, MICs, > 2µg/ml - > 8µg/ml). The most predominant resistance gene, blaNDM-1 (33.3%), was found to co-exist with blaOXA-23 (27.8%) or blaOXA-58 (16.7%), while blaOXA-420 (12.5%) was the least prevalent gene detected. The sequence types identified among the isolates were ST2 (33.3%), ST164 (16.7%), ST214 (16.7%), ST52 (16.7%), and ST16 (16.7%) according to MLST-Pasteur scheme. The study highlights the carriage of multiple carbapenemase genes, other AMR-encoding genes and efflux pumps in XDR clinical A. baumannii isolates. To the best of our knowledge, the study reports for the first time, the detection of ST2 OXA-23, NDM-1 and ST164 OXA-58, NDM-1-producing A. baumannii strains at the Korle Bu Teaching Hospital. These strains belong to high-risk clones and continuous surveillance through molecular epidemiological studies and public health interventions are urgently needed to control their spread in Ghana.